A Phase I/II Trial of the Potent Hsp90 Inhibitor STA-9090 Administered Once Weekly In Patients with Advanced Hematologic Malignancies

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Lancet, JE; Smith, BD; Bradley, R; Komrokji, RS; Teofilovici, F; Rizzieri, DA

Published Date

  • November 19, 2010

Published In

Volume / Issue

  • 116 / 21

Start / End Page

  • 1349 - 1350

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 52nd Annual Meeting of the American-Society-of-Hematology (ASH)

Conference Location

  • Orlando, FL

Conference Start Date

  • December 4, 2010

Conference End Date

  • December 7, 2010